Related Experiment Video
Updated: Mar 26, 2026

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
Immunotherapy for pancreatic cancer
Elias Kotteas1, Muhammad Wasif Saif2, Konstantinos Syrigos3,4
1Oncology Unit, 3rd Department of Internal Medicine, Sotiria General Hospital, Athens University School of Medicine, 152 Mesogeion Avenue, Athens, Greece. ilkotteas@hotmail.com.
Pancreatic cancer remains lethal, but immunotherapy offers new hope. Combining immunotherapy with chemotherapy or targeted therapy shows promise for improving patient survival and treatment outcomes.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Pancreatic cancer is a highly lethal malignancy with poor prognosis, especially in advanced stages.
- Current treatments like chemotherapy offer limited survival benefits.
- There is an urgent need for novel therapeutic strategies.
Purpose of the Study:
- To review the current landscape of immunotherapy in pancreatic cancer.
- To explore the potential of immunotherapy in combination with existing therapies.
- To highlight ongoing research and future directions.
Main Methods:
- Review of preclinical models demonstrating synergistic effects of chemotherapy/targeted therapy with immunotherapy.
- Analysis of clinical evidence for various immunotherapeutic approaches.
- Examination of ongoing clinical trials.
Main Results:
- Preclinical studies show synergy between chemotherapy/targeted therapy and immunotherapy.
- Evidence supports the efficacy of checkpoint inhibitors, vaccines, adoptive T cell therapy, monoclonal antibodies, and cytokines in pancreatic cancer patients.
- Multiple ongoing trials are investigating novel combinations.
Conclusions:
- Immunotherapy is a promising avenue for pancreatic cancer treatment.
- Combination strategies are being actively explored to enhance efficacy and minimize toxicity.
- Further research is crucial to optimize immunotherapy protocols for pancreatic cancer.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

